Which of the following individuals is at increased risk for developing Guillain-Barre syndrome?

Choice B rationale Guillain-Barre syndrome is an acute inflammatory demyelinating polyneuropathy often preceded by an infectious trigger. Approximately two thirds of cases occur following a respiratory or gastrointestinal illness, frequently involving Campylobacter jejuni, Cytomegalovirus, or Epstein-Barr virus. Molecular mimicry causes the immune system to produce antibodies that cross react with the gangliosides of the peripheral nervous system. This results in the characteristic ascending symmetrical paralysis and paresthesia observed in young adults and older populations post infection. Choice A rationale While advanced age and malignancy can impact the overall immune profile of a patient, lung cancer is not a primary or common risk factor for the development of Guillain-Barre syndrome. Paraneoplastic syndromes can occur with lung cancer, but they typically present differently than the acute, post infectious autoimmune attack on the myelin sheath seen in GBS. The epidemiological link between active solid tumors and the onset of this specific neurological disorder is significantly weaker than the link to recent infections. Choice C rationale Gestational diabetes involves insulin resistance during pregnancy and primarily affects maternal glucose metabolism and fetal growth. It does not inherently predispose a woman to the autoimmune peripheral nerve destruction characteristic of Guillain-Barre syndrome. While pregnancy itself causes physiological shifts in immune regulation, it is not a recognized major risk factor for GBS unless the patient also experiences a triggering viral or bacterial event during the peripartum or postpartum period. Choice D rationale Hypertension is a chronic cardiovascular condition characterized by systemic arterial pressures exceeding 130/80 mmHg. It is managed with various antihypertensives like ACE inhibitors or beta blockers to prevent stroke and renal failure. There is no established scientific or pathological mechanism connecting high blood pressure or standard antihypertensive therapy to the immune mediated demyelination of peripheral nerves. This patient represents the general population rather than a high risk group for this specific neurological emergency.